RankingsPricing
  1. JP-listed companies
  2. SAPPORO CLINICAL LABORATORY INC.
  3. Financials
  4. Diluted EPS

SAPPORO CLINICAL LABORATORY INC.JP:9776

Market cap
¥8.3B
P/E ratio
12.2x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndDiluted EPS (JPY)YoY (%)
Mar 31, 2025148.4+29.97%
Mar 31, 2024114.1-33.07%
Mar 31, 2023170.5-44.30%
Mar 31, 2022306.2+32.05%
Mar 31, 2021231.9+50.26%
Mar 31, 2020154.3+1.23%
Mar 31, 2019152.4-22.64%
Mar 31, 2018197+33.41%
Mar 31, 2017147.7-12.98%
Mar 31, 2016169.7+12.42%
Mar 31, 2015151+21.63%
Mar 31, 2014124.1+7.86%
Mar 31, 2013115.1+10.02%
Mar 31, 2012104.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)